For subscribers
Precision medicine gives cancer patients hope
Programme helps match patients to early-phase clinical trials of new drugs
Sign up now: Get ST's newsletters delivered to your inbox
Dr David Tan, lead investigator of the Integrated Molecular Analysis of Cancer Programme, with Madam Tan. Being matched with a clinical trial has helped Madam Tan, who had undergone six operations to remove various organs as her ovarian cancer spread.
ST PHOTO: SYAMIL SAPARI
Felicia Choo
For cancer patients who have had relapses despite multiple operations, the latest precision medicine may offer them hope.
A programme by the National University Cancer Institute Singapore (NCIS) is helping to match cancer patients with certain genetic profiles to early-phase clinical trials of new drugs.
